CTCX Carmell Corp.: ערך חשבונאי למניה

Carmell Corporation (CTCX) is a reputable biopharmaceutical player in the tissue regeneration niche. The GURU.Markets website features this chart of the reported book value per share, where the parameter mark equals -0.07. The company develops unique plasma materials for surgery, ensuring stable demand. However, current developments are in the early stages and operating cash flow is zero, necessitating support from legacy capital.

The book value per common share reflects the portion of equity attributable to each share after deducting all liabilities from the total asset value. The trend in this book value per common share allows for an assessment of the efficiency of R&D budget utilization by the Carmell Corporation (CTCX) biotech team, confirming the business's financial stability while navigating regulatory filters.